glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distr...

FDA Recall #D-0202-2025 — Class II — December 17, 2024

Recall #D-0202-2025 Date: December 17, 2024 Classification: Class II Status: Completed

Product Description

glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11

Reason for Recall

Failed Dissolution Specifications:

Recalling Firm

Amerisource Health Services LLC — Columbus, OH

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2,028 units (cartons of 30 individual unit doses)

Distribution

Nationwide in the USA

Code Information

Lot # 1012910, Exp Date: 04/30/2025

Status

Completed

Voluntary / Mandated

Voluntary: Firm initiated